Mutations in TP53 and the cohesin genes were observed in the CD69+-high group of adult AML, while they were nearly absent in that of pediatric AML (Fig. 7d, Additional file 10: Table S9). This evidence concerns the gene CD69 and acute myeloid leukemia.